Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share OACC
$10.71
-0.19%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-13 | View → |
| 8-K | 8-K | 2026-10-26 | View → |
| 4 | 4 | 2026-10-23 | View → |
| 8-K | 8-K | 2026-10-16 | View → |
| 8-K | 8-K | 2026-10-15 | View → |
| DEF 14A | DEF 14A | 2026-10-02 | View → |
| 10-Q | 10-Q | 2026-08-12 | View → |
| 10-Q | 10-Q | 2026-05-13 | View → |
| 10-K | 10-K | 2026-03-26 | View → |
| 10-Q | 10-Q | 2025-11-13 | View → |
| 8-K | 8-K | 2025-10-29 | View → |
| 8-K | 8-K | 2025-10-17 | View → |
| 10-Q | 10-Q | 2025-08-12 | View → |
| 8-K | 8-K | 2025-06-06 | View → |
| 10-Q | 10-Q | 2025-05-14 | View → |
| 10-K | 10-K | 2025-03-27 | View → |
| 8-K | 8-K | 2025-01-07 | View → |
| 8-K | 8-K | 2024-12-11 | View → |
| SC 13G | AQR CAPITAL MANAGEMENT LLC | 2024-11-07 | View → |
| 8-K | 8-K | 2024-11-05 | View → |
| 4 | 4 | 2024-10-31 | View → |
| 8-K | 8-K | 2024-10-31 | View → |
| SC 13G | Passive stake disclosure | 2024-10-30 | View → |
| 8-K | 8-K | 2024-10-25 | View → |
| S-1 | S-1 | 2024-10-04 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $10.71
- Market Cap
- $141.93 million
- 52-Week Range
- $10.50 – $10.93
- Average Volume
- 38K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
